The transcription factor Bcl11a is essential for B-1a cell maintenance during aging
Abstract
B-1a cells, a self-renewing B cell subset essential for innate immunity, produce natural IgM antibodies that defend against pathogens, yet mechanisms sustaining their maintenance during aging remain unclear. We report that aging B-1a cells exhibit hallmarks of decline, including DNA damage, apoptosis, and reduced proliferation, with striking sex-specific disparities: aged females retain higher B-1a cell numbers than males, correlating with enhanced glycolysis and chromatin accessibility. Motif analysis of accessible regions identified the transcription factor Bcl11a, which shows elevated chromatin accessibility and expression in aged female B-1a cells but declines in males. Bcl11a deletion reduced B-1a cell numbers, impaired viability, and increased apoptosis across sexes and ages. Mechanistically, Bcl11a sustains survival by upregulating antiapoptotic genes ( Mcl1 , Mdm2 , and Mdm4 ) to suppress p53-mediated apoptosis, as evidenced by partial rescue of viability defects in Bcl11a-deficient B-1a cells upon p53 deletion. Conversely, Bcl11a overexpression or Bcl11a-high B-1a cells from aged Bcl11a -eGFP reporter mice enhanced stress resistance. These findings establish Bcl11a as a key regulator of B-1a cell maintenance during aging and reveal its role in mitigating sex-dimorphic immune decline through transcriptional control of survival pathways.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (12)
Shasha Xu
Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University
Liangfeng Huang
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Anesthesiology and Perioperative medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University
Xingjie Liu
Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University
Linlin Zhang
Department of Applied Chemistry, Petroleum and Chemical Industry Key Laboratory of Organic Electrochemical Synthesis, State Key Laboratory of Green Chemical Synthesis and Conversion
Jing Wang
Hunan Cancer Hospital Changsha China
Yifeng Hu
Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University
Yi Yang
Xiaojie Shi
State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University
Chaohong Liu
Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology
Rong Wang
Zhichao Miao
Yong Yu